We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

BioForce Receives Key U.S. Patent Covering NanoArrayer

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

BioForce Nanosciences has received notice from the United States Patent and Trade Office of the March 7, 2006 issuance of patent number 7,008,769 entitled "Nanoscale Molecular Arrayer".

This is the second patent issued to the Company in 2006. This patent covers key elements of the NanoArrayer™ System, a premier BioForce product line.

The NanoArrayer™ System is a desktop molecular printing and surface patterning technology.

Dr. Curtis Mosher, Vice President of Research and Development at BioForce noted, "The NanoArrayer™ allows customers to design and print extremely small volumes of biomaterials and inorganic materials."

"This capability enables new developments in a broad spectrum of industries, including materials development, semiconductors, biotechnology, biomedical diagnostics, and drug discovery."

"This technology also enables new business opportunities for Companies operating within these markets." Dr. Mosher is co-author of this patent.

Company Founder and CEO, Dr. Eric Henderson, the primary author of this patent said, "We are very pleased with the issuance of this key NanoArrayer™ patent."

"This patent is an important addition to our intellectual property portfolio, further strengthening our product position in the marketplace. BioForce has a very exciting agenda for 2006."

"We are currently focused on placing NanoArrayers™ with key opinion makers and leaders in various fields of research."

"We are also expanding our sales force and production capabilities for this key product line to meet the anticipated response from multiple markets."